| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |